Portland Global Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Portland Global Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.55M	Buy	105,302 +1,169	+1%	+$35.1K	0.34%	50
2026 Q1	$3.03M	Buy	104,133 +1,129	+1%	+$32.8K	0.32%	53
2025 Q4	$2.7M	Sell	103,004 -3	-0%	-$77	0.29%	54
2025 Q3	$2.43M	Buy	103,007 +684	+0.7%	+$15.1K	0.27%	53
2025 Q2	$2.1M	Buy	+102,323	New	+$2.06M	0.25%	56

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Portland Global Advisors's IDNA Position: Q2 2026 in Review

Portland Global Advisors increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 1.1% in Q2 2026, buying an estimated $35.1K and bringing the position to 105,302 shares worth $3.55M. The position accounts for 0.34% of the portfolio, ranked #50.

Portland Global Advisors first reported a position in IDNA in Q2 2025 and has held it in 5 quarters since. 65 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Portland Global Advisors held 105,302 shares of iShares Genomics Immunology and Healthcare ETF worth $3.55M as of Q2 2026.
Portland Global Advisors bought 1,169 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $35.1K.
iShares Genomics Immunology and Healthcare ETF made up 0.34% of Portland Global Advisors's portfolio in Q2 2026, its #50 holding.
Portland Global Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2025 and has held it in 5 quarters since.
65 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Portland Global Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.